Advertisement

Topics

Ionis Licenses Centronuclear Myopathy Drug to Dynacure

05:52 EST 9 Nov 2017 | Contract Pharma

The agreement accelerates the potential finding of a new treatment for patients with CNM

Original Article: Ionis Licenses Centronuclear Myopathy Drug to Dynacure

NEXT ARTICLE

More From BioPortfolio on "Ionis Licenses Centronuclear Myopathy Drug to Dynacure"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...